Inspire Medical Systems Free Cash Flow (FCF) History (INSP)
Inspire Medical Systems reported $78.5M in free cash flow for fiscal 2025, a decrease of 13.88% from the previous fiscal year, with a free cash flow margin of 8.61%.
View full Inspire Medical Systems company overviewInspire Medical Systems free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $78.5M | −$12.6M | −13.88% | +8.61% |
| 2024 | 2024-12-31 | $91.1M | $90.1M | +8798.73% | +11.35% |
| 2023 | 2023-12-31 | $1.0M | −$1.4M | −58.59% | +0.16% |
| 2022 | 2022-12-31 | $2.5M | $27.3M | — | +0.61% |
| 2021 | 2021-12-31 | −$24.8M | $30.7M | — | −10.62% |
| 2020 | 2020-12-31 | −$55.5M | −$19.9M | — | −48.10% |
| 2019 | 2019-12-31 | −$35.6M | −$16.6M | — | −43.37% |
| 2018 | 2019-01-01 | −$18.9M | −$2.7M | — | −37.44% |
| 2017 | 2017-12-31 | −$16.2M | — | — | −56.72% |
Inspire Medical Systems quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $14.1M | $20.4M | — | +7.01% |
| Q1 2026 | 2026-03-31 | $3.1M | $18.2M | — | +1.53% |
| Q4 2025 | 2025-12-31 | $41.8M | −$20.3M | −32.73% | +15.54% |
| Q3 2025 | 2025-09-30 | $58.1M | $13.8M | +31.19% | +25.87% |
| Q2 2025 | 2025-06-30 | −$6.3M | $6.2M | — | −2.91% |
| Q1 2025 | 2025-03-31 | −$15.1M | −$12.3M | — | −7.51% |
| Q4 2024 | 2024-12-31 | $62.2M | $52.9M | +573.10% | +25.93% |
| Q3 2024 | 2024-09-30 | $44.3M | $47.6M | — | +21.79% |
| Q2 2024 | 2024-06-30 | −$12.5M | −$12.7M | — | −6.37% |
| Q1 2024 | 2024-03-31 | −$2.8M | $2.3M | — | −1.73% |
| Q4 2023 | 2023-12-31 | $9.2M | −$7.1M | −43.42% | +4.80% |
| Q3 2023 | 2023-09-30 | −$3.4M | −$10.8M | — | −2.19% |
| Q2 2023 | 2023-06-30 | $237,000 | $7.6M | — | +0.16% |
| Q1 2023 | 2023-03-31 | −$5.1M | $8.9M | — | −3.99% |
| Q4 2022 | 2022-12-31 | $16.3M | $16.1M | +8018.91% | +11.83% |
| Q3 2022 | 2022-09-30 | $7.5M | $9.0M | — | +6.86% |
| Q2 2022 | 2022-06-30 | −$7.4M | $4.4M | — | −8.07% |
| Q1 2022 | 2022-03-31 | −$14.0M | −$2.2M | — | −20.12% |
| Q4 2021 | 2021-12-31 | $201,000 | $4.9M | — | +0.26% |
| Q3 2021 | 2021-09-30 | −$1.5M | $8.6M | — | −2.41% |
| Q2 2021 | 2021-06-30 | −$11.8M | $13.9M | — | −22.24% |
| Q1 2021 | 2021-03-31 | −$11.7M | $3.3M | — | −29.05% |
| Q4 2020 | 2020-12-31 | −$4.7M | $1.8M | — | −10.25% |
| Q3 2020 | 2020-09-30 | −$10.1M | −$6.1M | — | −28.25% |
| Q2 2020 | 2020-06-30 | −$25.6M | −$11.8M | — | −210.39% |
| Q1 2020 | 2020-03-31 | −$15.0M | −$3.8M | — | −70.41% |
| Q4 2019 | 2019-12-31 | −$6.5M | −$3.7M | — | −24.23% |
| Q3 2019 | 2019-09-30 | −$4.0M | −$455,000 | — | −19.21% |
| Q2 2019 | 2019-06-30 | −$13.8M | −$7.7M | — | −76.76% |
| Q1 2019 | 2019-03-31 | −$11.2M | −$4.8M | — | −69.03% |
| Q4 2018 | 2019-01-01 | −$2.8M | $559,000 | — | −16.79% |
| Q3 2018 | 2018-09-30 | −$3.6M | −$302,000 | — | −27.22% |
| Q2 2018 | 2018-06-30 | −$6.2M | −$2.1M | — | −56.56% |
| Q1 2018 | 2018-03-31 | −$6.4M | −$859,000 | — | −63.98% |
| Q4 2017 | 2017-12-31 | −$3.3M | — | — | −33.53% |
| Q3 2017 | 2017-09-30 | −$3.3M | — | — | −44.71% |
| Q2 2017 | 2017-06-30 | −$4.0M | — | — | −66.98% |
| Q1 2017 | 2017-03-31 | −$5.6M | — | — | −105.08% |
Inspire Medical Systems free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$55.5M to $78.5M, a net increase of $134.0M. Inspire Medical Systems's latest reported quarter, Q2 2026, generated $14.1M in free cash flow, an increase of $20.4M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Inspire Medical Systems filings at SEC.gov ↗